Medicines for cancer mechanism of action and clinical pharmacology of chemo, hormonal, targeted, and immunotherapies

Medicines for Cancer: Mechanism of Action and Clinical Pharmacology of Chemo, Hormonal, Targeted, and Immunotherapies covers most known anti-cancer therapeutics. Cancer is the second leading cause of death worldwide, with its various forms resulting in nearly one out of every six mortalities each ye...

Descripción completa

Detalles Bibliográficos
Otros Autores:	De, Surya K., autor (autor)
Formato:	Libro electrónico
Idioma:	Inglés
Publicado:	Amsterdam : Elsevier Inc [2023]
Materias:	Cáncer > Quimioterapia. Farmacología clínica.
Ver en Universidad de Navarra:	https://unika.unav.edu/discovery/fulldisplay?docid=alma991011499633008016&context=L&vid=34UNAV_INST:VU1&search_scope=34UNAV_TODO&tab=34UNAV_TODO&lang=es

Tabla de Contenidos:

Front Cover
Medicines for Cancer
Medicines for Cancer: MECHANISM OF ACTION AND CLINICAL PHARMACOLOGY OF CHEMO, HORMONAL, TARGETED, AND IMMUNOTHERAPIES
Copyright
Medical advice disclaimer
Contents
About the author
Preface
Common abbreviations and acronyms
1 - Drug nomenclature
1.1 Generic formula
References
2 - Chemotherapy
2.1 Alkylating antineoplastic agents
2.2 Nitrosoureas
2.3 Antimetabolites
2.4 Antitumor antibiotics
2.4.1 Anthracyclines
2.4.2 Nonanthracyclines
2.5 Topoisomerase inhibitors
2.6 Mitotic inhibitors (antimicrotubule agents)
2.7 Corticosteroids
2.8 Other chemotherapy drugs
2.9 US FDA-approved current chemotherapy agents
2.10 Albumin-bound paclitaxel
2.10.1 Indications (medical uses)
2.10.2 Metastatic breast cancer
2.10.3 Dosage and administration
2.10.4 Mechanism of action
2.10.5 Pharmacokinetics
2.10.6 Side effects
2.11 Amifostine
2.11.1 Indications (medical uses)
2.11.2 Dosage and administration
2.11.3 Mechanism of action
2.11.4 Pharmacokinetics
2.11.5 Side effects
2.12 Arsenic trioxide
2.12.1 Indications (medical uses)
2.12.2 Dosage and administration
2.12.3 Mechanism of action
2.12.4 Pharmacokinetics
2.12.5 Side effects
2.13 Asparaginase Erwinia chrysanthemi
2.13.1 Indications (medical uses)
2.13.2 Dosage and administration
2.13.3 Mechanism of action
2.13.4 Pharmacokinetics
2.13.5 Side effects
2.14 Azacitidine
2.14.1 Indications (medical uses)
2.14.2 Dosage and administration
2.14.3 Mechanism of action
2.14.4 Pharmacokinetics
2.14.5 Side effects
2.15 Bendamustine
2.15.1 Indications (medical uses)
2.15.2 Dosage and administration
2.15.3 Mechanism of action
2.15.4 Pharmacokinetics
2.15.5 Side effects
2.16 Bleomycin.
2.16.1 Indications (medical uses)
2.16.2 Dosage and administration
2.16.3 Mechanism of action
2.16.4 Pharmacokinetics
2.16.5 Metabolism
2.16.6 Side effects
2.17 Busulfan
2.17.1 Indications (medical uses)
2.17.2 Dosage and administration
2.17.3 Mechanism of action
2.17.4 Pharmacokinetics
2.17.5 Side effects
2.18 Cabazitaxel
2.18.1 Indications (medical uses)
2.18.2 Dosage and administration
2.18.3 Mechanism of action
2.18.4 Pharmacokinetics
2.18.5 Side effects
2.19 Calaspargase pegol-mknl
2.19.1 Indications (medical uses)
2.19.2 Dosage and administration
2.19.3 Mechanism of action
2.19.4 Pharmacokinetics
2.19.5 Side effects
2.20 Capecitabine
2.20.1 Indications (medical uses)
2.20.2 Dosage and administration
2.20.3 Mechanism of action
2.20.4 Pharmacokinetics
2.20.5 Side effects
2.21 Carboplatin
2.21.1 Indications (medical uses)
2.21.2 Dosage and administration
2.21.3 Mechanism of action
2.21.4 Pharmacokinetics
2.21.5 Side effects
2.22 Carmustine
2.22.1 Indications (medical uses)
2.22.2 Dosage and administration
2.22.3 Mechanism of action
2.22.4 Pharmacokinetics
2.22.5 Side effects
2.23 Chlorambucil
2.23.1 Indications (medical uses)
2.23.2 Dosage and administration
2.23.3 Mechanism of action
2.23.4 Pharmacokinetics
2.23.5 Side effects
2.24 Cisplatin
2.24.1 Indications (medical uses)
2.24.2 Dosage and administration
2.24.3 Mechanism of action
2.24.4 Pharmacokinetics
2.24.5 Side effects
2.25 Cladribine
2.25.1 Indications (medical uses)
2.25.2 Dosage and administration
2.25.3 Mechanism of action
2.25.4 Pharmacokinetics
2.25.5 Side effects
2.26 Clofarabine
2.26.1 Indications (medical uses)
2.26.2 Dosage and administration
2.26.3 Mechanism of action.
2.26.4 Pharmacokinetics
2.26.5 Side effects
2.27 Cyclophosphamide
2.27.1 Indications (medical uses)
2.27.2 Dosage and administration
2.27.3 Mechanism of action
2.27.4 Pharmacokinetics
2.27.5 Side effects
2.28 Cytarabine
2.28.1 Indications (medical uses)
2.28.2 Dosage and administration
2.28.3 Mechanism of action
2.28.4 Pharmacokinetics
2.28.5 Side effects
2.29 Dacarbazine
2.29.1 Indications (medical uses)
2.29.2 Dosage and administration
2.29.3 Mechanism of action
2.29.4 Pharmacokinetics
2.29.5 Side effects
2.30 Dactinomycin
2.30.1 Indications (medical uses)
2.30.2 Dosage and administration
2.30.3 Mechanism of action
2.30.4 Pharmacokinetics
2.30.5 Side effects
2.31 Daunorubicin
2.31.1 Indications (medical uses)
2.31.2 Dosage and administration
2.31.3 Mechanism of action
2.31.4 Pharmacokinetics
2.31.5 Side effects
2.32 Decitabine
2.32.1 Indications (medical uses)
2.32.2 Dosage and administration
2.32.3 Mechanism of action
2.32.4 Pharmacokinetics
2.32.5 Side effects
2.33 Dexamethasone
2.33.1 Dosage and administration
2.33.2 Mechanism of action
2.33.3 Pharmacokinetics
2.33.4 Side effects
2.34 Docetaxel
2.34.1 Indications (medical uses)
2.34.2 Dosage and administration
2.34.3 Mechanism of action
2.34.4 Pharmacokinetics
2.34.5 Side effects
2.35 Doxorubicin
2.35.1 Indications (medical uses)
2.35.2 Dosage and administration
2.35.3 Mechanism of action
2.35.4 Pharmacokinetics
2.35.5 Side effects
2.36 Doxorubicin liposome
2.36.1 Indications (medical uses)
2.36.2 Dosage and administration
2.36.3 Mechanism of action
2.36.4 Pharmacokinetics
2.36.5 Side effects
2.37 Epirubicin
2.37.1 Indications (medical uses)
2.37.2 Dosage and administration
2.37.3 Mechanism of action.
2.37.4 Pharmacokinetics
2.37.5 Side effects
2.38 Eribulin mesylate
2.38.1 Indications (medical uses)
2.38.2 Dosage and administration
2.38.3 Mechanism of action
2.38.4 Pharmacokinetics
2.38.5 Side effects
2.39 Etoposide
2.39.1 Indications (medical uses)
2.39.2 Dosage and administration
2.39.3 Mechanism of action
2.39.4 Pharmacokinetics
2.39.5 Side effects
2.40 Fludarabine
2.40.1 Indications (medical uses)
2.40.2 Dosage and administration
2.40.3 Mechanism of action
2.40.4 Pharmacokinetics
2.40.5 Side effects
2.41 5-Fluorouracil
2.41.1 Indications (medical uses)
2.41.2 Dosage and administration
2.41.3 Mechanism of action
2.41.4 Pharmacokinetics
2.41.5 Side effects
2.42 Gemcitabine
2.42.1 Indications (medical uses)
2.42.2 Dosage and administration
2.42.3 Mechanism of action
2.42.4 Pharmacokinetics
2.42.5 Side effects
2.43 Hydroxyurea
2.43.1 Indications (medical uses)
2.43.2 Dosage and administration
2.43.3 Mechanism of action
2.43.4 Pharmacokinetics
2.43.5 Side effects
2.44 Idarubicin
2.44.1 Indications (medical uses)
2.44.2 Dosage and administration
2.44.3 Mechanism of action
2.44.4 Pharmacokinetics
2.44.5 Side effects
2.45 Ifosfamide
2.45.1 Indications (medical uses)
2.45.2 Dosage and administration
2.45.3 Mechanism of action
2.45.4 Pharmacokinetics
2.45.5 Side effects
2.46 Irinotecan
2.46.1 Indications (medical uses)
2.46.2 Dosage and administration
2.46.3 Mechanism of action
2.46.4 Pharmacokinetics
2.46.5 Side effects
2.47 Ixabepilone
2.47.1 Indications (medical uses)
2.47.2 Dosage and administration
2.47.3 Mechanism of action
2.47.4 Pharmacokinetics
2.47.5 Side effects
2.48 Lomustine
2.48.1 Indications (medical uses)
2.48.2 Dosage and administration.
2.48.3 Mechanism of action
2.48.4 Pharmacokinetics
2.48.5 Side effects
2.49 Lurbinectedin
2.49.1 Indications (medical uses)
2.49.2 Dosage and administration
2.49.3 Mechanism of action
2.49.4 Pharmacokinetics
2.49.5 Side effects
2.50 Lutetium Lu 177-dotatate
2.50.1 Indications (medical uses)
2.50.2 Dosage and administration
2.50.3 Mechanism of action
2.50.4 Pharmacokinetics
2.50.5 Side effects
2.51 Mechlorethamine
2.51.1 Indications (medical uses)
2.51.2 Dosage and administration
2.51.3 Mechanism of action
2.51.4 Pharmacokinetics
2.51.5 Side effects
2.52 Melphalan
2.52.1 Indications (medical uses)
2.52.2 Dosage and administration
2.52.3 Mechanism of action
2.52.4 Pharmacokinetics
2.52.5 Side effects
2.53 Mercaptopurine
2.53.1 Indications (medical uses)
2.53.2 Dosage and administration
2.53.3 Mechanism of action
2.53.4 Pharmacokinetics
2.53.5 Side effects
2.54 Methotrexate
2.54.1 Indications (medical uses)
2.54.2 Dosage and administration
2.54.3 Mechanism of action
2.54.4 Pharmacokinetics
2.54.5 Side effects
2.55 Mitomycin-C
2.55.1 Indications (medical uses)
2.55.2 Dosage and administration
2.55.3 Mechanism of action
2.55.4 Pharmacokinetics
2.55.5 Side effects
2.56 Mitoxantrone
2.56.1 Indications (medical uses)
2.56.2 Dosage and administration
2.56.3 Mechanism of action
2.56.4 Pharmacokinetics
2.56.5 Side effects
2.57 Nelarabine
2.57.1 Indications (medical uses)
2.57.2 Dosage and administration
2.57.3 Mechanism of action
2.57.4 Pharmacokinetics
2.57.5 Side effects
2.58 Oxaliplatin
2.58.1 Indications (medical uses)
2.58.2 Dosage and administration
2.58.3 Mechanism of action
2.58.4 Pharmacokinetics
2.58.5 Side effects
2.59 Paclitaxel
2.59.1 Indications (medical uses).

Medicines for cancer mechanism of action and clinical pharmacology of chemo, hormonal, targeted, and immunotherapies

Ejemplares similares